Risk factors associated with the development of intestinal metaplasia in first-degree relatives of gastric cancer patients

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 12, 2005, Pages 2982-2986

  Leung, Wai K ^a   Ng, Enders K W ^a   Chan, Wing Y ^a   Auyeung, Alex C M ^a   Chan, Kui Fat ^a   Lam, Candice C H ^a   Chan, Francis K L ^a   Lau, James Y W ^a   Sung, Joseph J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RISK; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GASTROSCOPY; HELICOBACTER PYLORI; HIGH RISK PATIENT; HUMAN; INFECTION; INTESTINE METAPLASIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; RELATIVE; RISK FACTOR; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOGENESIS; WATER SUPPLY;

ADENOCARCINOMA; ADULT; CHI-SQUARE DISTRIBUTION; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINES; LOGISTIC MODELS; MALE; METAPLASIA; MIDDLE AGED; RISK FACTORS; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS;

EID: 30344471104     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0181     Document Type: Article

References (27)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC CancerBase No. 5. Lyon (France): IARC Press; 2001.
2. Zanghieri G, Di Gregorio C, Sacchetti C, et al. Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. Cancer 1990;66:2047-51.
3. La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. Cancer 1992;70:50-5.
4. Palli D, Galli M, Caporaso NE, et al. Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev 1994;3:15-8.
5. Brenner H, Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer 2000;88:274-9.
6. Dhillon PK, Farrow DC, Vaughan TL, et al. Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer 2001;93:148-52.
7. Kondo T, Toyoshima H, Tsuzuki Y, et al. Aggregation of stomach cancer history in parents and offspring in comparison with other sites. Int J Epidemiol 2003;32:579-83.
8. Brenner H, Bode G, Boeing H. Helicobacter pylori infection among offspring of patients with stomach cancer. Gastroenterology 2000;118:31-5.
9. Munoz SE, Ferraroni M, La Vecchia C, Decarli A. Gastric cancer risk factors in subjects with family history. Cancer Epidemiol Biomarkers Prev 1997;6:137-40.
10. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-40.
11. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
12. Leung WK, Sung JJ. Review article: intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther 2002;16:1209-16.
13. Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter therapy. J Natl Cancer Inst 2000;92:1881-8.
14. Sung JJ, Lin SR, Ching JY, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000;119:7-14.
15. Leung WK, Lin SR, Ching JY, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 2004;53:1244-9.
16. El-Omar EM, Oien K, Murray LS, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 2000;118:22-30.
17. Genta RM. Review article: Gastric atrophy and atrophic gastritis-nebulous concepts in search of a definition. Aliment Pharmacol Ther 1998;12 Suppl 1:17-23.
18. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
19. Wong WM, Lam SK, Xia HH, et al. Accuracy of a new near patient test for the diagnosis of Helicobacter pylori infection in Chinese. J Gastroenterol Hepatol 2002;17:1272-7.
20. Wong BCY, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187-94.
21. Malfertheiner P, Megraud F, O'Morain, et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 consensus report. Aliment Pharmacol Ther 2002;16:167-80.
22. Chang YW, Han YS, Lee DK, et al. Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients. Int J Cancer 2002;101:469-74.
23. Goodman KJ, Correa P. Transmission of Helicobacter pylori among siblings. Lancet 2000;355:358-62.
24. Malaty HM, Nyren O. Epidemiology of Helicobacter pylori infection. Helicobacter 2003;8 Suppl 1:8-12.
25. Yu J, Leung WK, Go MY, et al. Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut 2002;51:480-4.
26. Groves FD, Perez-Perez G, Zhang L, et al. Serum antibodies to Helicobacter pylori and the CagA antigen do not explain differences in the prevalence of precancerous gastric lesions in two Chinese populations with contrasting gastric cancer rates. Cancer Epidemiol Biomarkers Prev 2002;11:1091-4.
27. Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JW. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002;50:378-81.